This past winter, hospitals and clinics across Indiana filled up with patients suffering from different respiratory illnesses that have much the same symptoms: COVID-19, flu and RSV. And many more ...

Basel, 24 December 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its COVID-19 At-Home ...

A sign at a diagnostics site for Swiss pharmaceutical giant Roche is seen as the company said problems at a new warehouse delayed the dispatch of some products ZURICH (Reuters) -Roche said on Friday ...

The Elecsys® SARS-CoV-2 Antigen test is an automated laboratory assay intended as an aid in the diagnosis of SARS-CoV-2 infection This new solution will run on all Roche cobas e immunochemistry ...

Used with the cobas® 5800, 6800 and 8800 systems, cobas Respiratory 4-flex simultaneously detects and differentiates the four most common respiratory viruses, helping to ensure confidence in diagnosis ...

The rollout comes amid long lines at testing sites and President Joe Biden's promise to increase the number of tests available. Healthcare giant Roche will roll out "tens of millions" of at-home Covid ...

On Wednesday morning before the opening bell, Roche announced they will launch in late September a new Rapid Antigen Test development for the detection of Severe Acute Respiratory Syndrome COV-2 (SARS ...

Roche secures CE Mark approval for its automated mass spectrometry antibiotic monitoring reagents, expanding clinical ...

The Roche drug is an antibody designed to bind to and block TIGIT, a so-called checkpoint protein that keeps immune cells from attacking cancer cells. Blocking it is hoped to offer a new way to ...

Roche’s cobas BV/CV assay gains CE Mark, enabling accurate, rapid diagnosis of bacterial vaginosis and candida vaginitis.

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of the new cobas® 6800/8800 systems version 2.0 and software ...